NASDAQ:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free IMCC Stock Alerts $0.55 -0.01 (-1.77%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.54▼$0.6450-Day Range$0.30▼$1.0852-Week Range$0.19▼$1.43Volume249,659 shsAverage Volume553,532 shsMarket Capitalization$7.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get IM Cannabis alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About IM Cannabis Stock (NASDAQ:IMCC)IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.Read More IMCC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IMCC Stock News HeadlinesApril 19, 2024 | investorplace.comPuff, Puff, Invest: 3 Top Cannabis Stock Picks to Celebrate 4/20April 9, 2024 | finanznachrichten.deAegis Capital Corp. Acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp.April 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 9, 2024 | prnewswire.comIM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli MarketApril 1, 2024 | prnewswire.comIMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patientsMarch 30, 2024 | msn.comGermany to Usher in New Era with Marijuana Legalization Law Effective April 1stMarch 28, 2024 | msn.comRockford man charged with selling crack cocaine, cannabisMarch 28, 2024 | prnewswire.comIM Cannabis Reports 2023 Financial ResultsApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 25, 2024 | prnewswire.comIMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis LegalizationMarch 20, 2024 | prnewswire.comIM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ETMarch 18, 2024 | msn.comBusinesses ready to go on Kentucky medical marijuana. Why can't they proceed?February 28, 2024 | finanznachrichten.deIM Cannabis Corp.: IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy companyFebruary 28, 2024 | finance.yahoo.comKadimastem Takes Another Step Towards Signing the Merger Agreement with Nasdaq Listed IMCCFebruary 28, 2024 | finance.yahoo.comIMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy companyFebruary 15, 2024 | thestreet.comIM Cannabis Corp. NewsJanuary 12, 2024 | finanznachrichten.deIM Cannabis Corp.: IMC Reschedules the Final Payment of the Oranim Pharmacy AcquisitionJanuary 12, 2024 | finance.yahoo.comIMC Reschedules the Final Payment of the Oranim Pharmacy AcquisitionJanuary 2, 2024 | finanznachrichten.deIM Cannabis Corp.: IMC Announces the Conclusion of the Planning and Construction Legal ProceedingsJanuary 2, 2024 | finance.yahoo.comIMC Announces the Conclusion of the Planning and Construction Legal ProceedingsDecember 8, 2023 | finance.yahoo.comNew Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in November 2023November 8, 2023 | finance.yahoo.comIM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ETOctober 10, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial OfficerOctober 10, 2023 | finance.yahoo.comIM Cannabis Announces the appointment of Uri Birenberg as Chief Financial OfficerOctober 6, 2023 | cbsnews.comMichigan man growing cannabis worth millions won't face major charges, court saysSeptember 25, 2023 | msn.com"We got this wrong:" Minnesota's first legal cannabis director quits after one daySeptember 12, 2023 | msn.comMum defends decision to smoke medical marijuana while pregnantSee More Headlines Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today4/26/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolNASDAQ:IMCC CUSIPN/A CIK1792030 Webwww.imcannabis.com Phone972-54-433-1111FaxN/AEmployees95Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,040,000.00 Net Margins-16.42% Pretax Margin-19.38% Return on Equity-44.25% Return on Assets-16.48% Debt Debt-to-Equity Ratio0.03 Current Ratio0.74 Quick Ratio0.44 Sales & Book Value Annual Sales$36.15 million Price / Sales0.21 Cash FlowN/A Price / Cash FlowN/A Book Value$0.76 per share Price / Book0.75Miscellaneous Outstanding Shares13,390,000Free Float12,599,000Market Cap$7.59 million OptionableNot Optionable Beta1.03 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Marc Lustig M.B.A. (Age 50)M.Sc., Executive Chairman Comp: $94.91kMr. Oren ShusterCEO & DirectorMr. Uri Birenberg (Age 48)Chief Financial Officer Comp: $237.95kMr. Richard BallaChief Executive Officer of AdjupharmAdvocate Michal Lebovitz NissimovGeneral CounselKey CompetitorsSmart for LifeNASDAQ:SMFLMannatechNASDAQ:MTEXBiofronteraNASDAQ:BFRITFF PharmaceuticalsNASDAQ:TFFPASLAN PharmaceuticalsNASDAQ:ASLNView All Competitors IMCC Stock Analysis - Frequently Asked Questions How have IMCC shares performed in 2024? IM Cannabis' stock was trading at $0.3570 at the beginning of 2024. Since then, IMCC stock has increased by 54.3% and is now trading at $0.5510. View the best growth stocks for 2024 here. Are investors shorting IM Cannabis? IM Cannabis saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 342,900 shares, an increase of 249.5% from the March 31st total of 98,100 shares. Based on an average daily trading volume, of 662,600 shares, the days-to-cover ratio is currently 0.5 days. Currently, 3.7% of the shares of the stock are sold short. View IM Cannabis' Short Interest. When is IM Cannabis' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our IMCC earnings forecast. How were IM Cannabis' earnings last quarter? IM Cannabis Corp. (NASDAQ:IMCC) released its quarterly earnings data on Thursday, March, 28th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by $0.02. The company had revenue of $7.86 million for the quarter, compared to analyst estimates of $7.59 million. IM Cannabis had a negative trailing twelve-month return on equity of 44.25% and a negative net margin of 16.42%. When did IM Cannabis' stock split? IM Cannabis's stock reverse split on the morning of Wednesday, November 16th 2022. The 1-10 reverse split was announced on Wednesday, November 16th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IMCC) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
